Metoprolol vs placebo: Non‐fatal cardiovascular events
Metoprolol showed no clear difference in nonfatal cardiovascular event, 6 months5 compared with placebo (low certainty).
What each review found
Include earlier review versions| Finding | Effect | Studies | GRADE certainty |
|---|---|---|---|
Metoprolol vs placebo Nonfatal cardiovascular event, 6 months5 · patients of any age with AAA less than 30 mm in diameter Metoprolol showed no clear difference in nonfatal cardiovascular event, 6 months5 compared with placebo (low certainty). Pharmacological treatment of vascular risk factors for reducing mortality and cardiovascular events in… (2017) · Cochrane Headline outcomes only | OR 1.41 [0.59, 3.35] | 1 study · 227 participants | Low |
Findings are shown side by side, never pooled across reviews.
The reviews
| Review | Searched up to | Included studies | AMSTAR 2 |
|---|---|---|---|
| Pharmacological treatment of vascular risk factors for reducing mortality and cardiovascular events in patients with abdominal aortic… 2017 · Cochrane Headline outcomes only | Not reported | list not extracted yet | Not assessed |
Studies behind the findings
None of these reviews ties its included studies to this outcome in the data here. Cochrane reviews and reviews with headline outcomes only do not list their studies yet.
How reviews are matched to this question
Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.